UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

Structural and functional similarities in bunyaviruses: Perspectives for pan‐bunya antivirals

Reviews in medical virology, 2019-05, Vol.29 (3), p.e2039-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

A robust human norovirus replication model in zebrafish larvae

PLoS pathogens, 2019-09, Vol.15 (9), p.e1008009

2019

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Human organoid technology for virus research

Frontiers in cellular and infection microbiology, 2023-03, Vol.13, p.1155252-1155252

2023

Link zum Volltext

Verfügbarkeit prüfen

Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral Therapy

Viruses, 2019-02, Vol.11 (2), p.173

2019

Link zum Volltext

Verfügbarkeit prüfen

The Viral Polymerase Inhibitor 2′-C-Methylcytidine Inhibits Norwalk Virus Replication and Protects against Norovirus-Induced Diarrhea and Mortality in a Mouse Model

Journal of Virology, 2013-11, Vol.87 (21), p.11798-11805

2013

Link zum Volltext

Verfügbarkeit prüfen

Multiplexed multicolor antiviral assay amenable for high-throughput research

Nature communications, 2024-01, Vol.15 (1), p.42-42, Article 42

2024

Link zum Volltext

Verfügbarkeit prüfen

Screening and in vitro antiviral assessment of small molecules against fluorescent protein-expressing Bunyamwera virus in a cell-based assay using high-content imaging

Antiviral chemistry & chemotherapy, 2021, Vol.29, p.204020662110334-20402066211033478

2021

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Identification of active compounds

Antiviral chemistry & chemotherapy, 2021, Vol.29, p.204020662110268-20402066211026852

2021

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies

Antiviral chemistry & chemotherapy, 2021, Vol.29, p.204020662110251-20402066211025175

2021

Link zum Volltext

Verfügbarkeit prüfen

Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections

Microorganisms (Basel), 2021-07, Vol.9 (8), p.1599

2021

Link zum Volltext

Verfügbarkeit prüfen

A Novel Class of Norovirus Inhibitors Targeting the Viral Protease with Potent Antiviral Activity In Vitro and In Vivo

Viruses, 2021-09, Vol.13 (9), p.1852

2021

Link zum Volltext

Verfügbarkeit prüfen

The Role of Histo-Blood Group Antigens and Microbiota in Human Norovirus Replication in Zebrafish Larvae

Microbiology spectrum, 2022-12, Vol.10 (6), p.e0315722-e0315722

2022

Link zum Volltext

Verfügbarkeit prüfen

Structural Investigations on Novel Non-Nucleoside Inhibitors of Human Norovirus Polymerase

Viruses, 2022-12, Vol.15 (1), p.74

2022

Link zum Volltext

Verfügbarkeit prüfen

Ex vivo gut cultures of Aedes aegypti are efficiently infected by mosquito-borne alpha- and flaviviruses

Microbiology spectrum, 2023-10, Vol.11 (5), p.e0519522-e0519522

2023

Link zum Volltext

Verfügbarkeit prüfen

Post-exposure antiviral treatment of norovirus infections effectively protects against diarrhea and reduces virus shedding in the stool in a mortality mouse model

Antiviral research, 2016-08, Vol.132, p.76-84

2016

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a Novel Class of Norovirus Inhibitors with High Barrier of Resistance

Pharmaceuticals (Basel, Switzerland), 2021-09, Vol.14 (10), p.1006

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of 3D Human Intestinal Organoids as a Platform for EV-A71 Antiviral Drug Discovery

Cells (Basel, Switzerland), 2023-04, Vol.12 (8), p.1138

2023

Link zum Volltext

Verfügbarkeit prüfen

Structure–Activity Relationship Studies on Novel Antiviral Agents for Norovirus Infections

Microorganisms (Basel), 2021-08, Vol.9 (9), p.1795

2021

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens”

EBioMedicine, 2021-07, Vol.69, p.103454-103454, Article 103454

2021

Link zum Volltext

Verfügbarkeit prüfen

Norovirus: Targets and tools in antiviral drug discovery

Biochemical pharmacology, 2014-09, Vol.91 (1), p.1-11

2014

Link zum Volltext

Verfügbarkeit prüfen

A signature of differential gene expression in bronchoalveolar lavage fluid predicts mortality in influenza-associated pulmonary aspergillosis

Intensive care medicine, 2023-02, Vol.49 (2), p.254-257

2023

Link zum Volltext

Verfügbarkeit prüfen

Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients

Nature communications, 2020-08, Vol.11 (1), p.4253-4253, Article 4253

2020

Link zum Volltext

Verfügbarkeit prüfen

Molnupiravir inhibits human norovirus and rotavirus replication in 3D human intestinal enteroids

Antiviral research, 2024-03, Vol.223, p.105839-105839, Article 105839

2024

Link zum Volltext

Verfügbarkeit prüfen

Favipiravir at high doses has potent antiviral activity in SARS-CoV-2–infected hamsters, whereas hydroxychloroquine lacks activity

Proceedings of the National Academy of Sciences - PNAS, 2020-10, Vol.117 (43), p.26955-26965

2020

Link zum Volltext

Verfügbarkeit prüfen

Anti-norovirus activity of C7-modified 4-amino-pyrrolo[2,1-f][1,2,4]triazine C-nucleosides

European journal of medicinal chemistry, 2020-06, Vol.195, p.112198, Article 112198

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Antiviral Research
(7)
Journal Of Virology
(4)
Viruses
(4)
Antiviral Chemistry & Chemotherapy
(3)
Nature Communications
(3)
Bio-Protocol
(2)
Cytokine
(2)
Ebiomedicine
(2)
Journal Of Antimicrobial Chemotherapy
(2)
Microbiology Spectrum
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Structural and functional similarities in bunyaviruses: Perspectives for pan‐bunya antivirals

A robust human norovirus replication model in zebrafish larvae

Editorial: Human organoid technology for virus research

Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral Therapy

The Viral Polymerase Inhibitor 2′-C-Methylcytidine Inhibits Norwalk Virus Replication and Protects against Norovirus-Induced Diarrhea and Mortality in a Mouse Model

Multiplexed multicolor antiviral assay amenable for high-throughput research

Screening and in vitro antiviral assessment of small molecules against fluorescent protein-expressing Bunyamwera virus in a cell-based assay using high-content imaging

Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Identification of active compounds

Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies

Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections

A Novel Class of Norovirus Inhibitors Targeting the Viral Protease with Potent Antiviral Activity In Vitro and In Vivo

The Role of Histo-Blood Group Antigens and Microbiota in Human Norovirus Replication in Zebrafish Larvae

Structural Investigations on Novel Non-Nucleoside Inhibitors of Human Norovirus Polymerase

Ex vivo gut cultures of Aedes aegypti are efficiently infected by mosquito-borne alpha- and flaviviruses

Post-exposure antiviral treatment of norovirus infections effectively protects against diarrhea and reduces virus shedding in the stool in a mortality mouse model

Discovery of a Novel Class of Norovirus Inhibitors with High Barrier of Resistance

Evaluation of 3D Human Intestinal Organoids as a Platform for EV-A71 Antiviral Drug Discovery

Structure–Activity Relationship Studies on Novel Antiviral Agents for Norovirus Infections

Corrigendum to “itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens”

Norovirus: Targets and tools in antiviral drug discovery

A signature of differential gene expression in bronchoalveolar lavage fluid predicts mortality in influenza-associated pulmonary aspergillosis

Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients

Molnupiravir inhibits human norovirus and rotavirus replication in 3D human intestinal enteroids

Favipiravir at high doses has potent antiviral activity in SARS-CoV-2–infected hamsters, whereas hydroxychloroquine lacks activity

Anti-norovirus activity of C7-modified 4-amino-pyrrolo[2,1-f][1,2,4]triazine C-nucleosides

Suchergebnisse filtern